Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) and PTC Therapeutics (NASDAQ:PTCT – Get Free Report) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation. Volatility and Risk Amphastar Pharmaceuticals has a […]
Gene Therapy Market is Set to Soar at a Revenue of US$ 19 2 Billion By 2030 | Astute Analytica | medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.
Royalty Pharma (RPRX) to Purchase Up to $1 5B of PTC Therapeutics Royalty on Evrysdi streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.